Drupal.behaviors.print = function(context) {window.print();window.close();}>
TcLand Licenses Patents to Develop RA Companion Dx
July 07, 2010
TcLand Licenses Patents to Develop RA Companion Dx
The French firm also said it has received $564,000 in funding for the project.
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Qiagen Licenses Two Biomarkers for CDx Development
May 31, 2013 / GenomeWeb Daily News
TcLand Teams with Radboud Univ. on Biomarkers for RA Drug Response
October 12, 2011 / GenomeWeb Daily News
TcLand Expression Receives $1.7M to Validate Companion Dx for Rheumatoid Arthritis
June 17, 2011 / GenomeWeb Daily News
OncoMethylome, GSK Agree on Possible Use of DNA Methylation Biomarker
September 23, 2010 / GenomeWeb Daily News
Study of Normally Silent Somatic Tissue Genes Leads to Potential Prognostic Signature in Lung Cancer
May 23, 2013 / GenomeWeb Daily News